David Hague Early Career Investigator of the Year Award

Celebrating Excellence in Dementia Research

The David Hague Early Career Investigator of the Year Award, worth £25,000 in research expenses with a £1,500 personal prize, is presented each year to the most outstanding early career researcher in the field of biomedical dementia research.

The Award is judged by an external panel of prominent international researchers, who look for excellence in scientific research, a significant contribution to the field and quality of scientific writing in an essay. Entries should demonstrate excellence across all areas of our Early Career Research Framework.

The deadline for applications for our 2020 Award is Friday 27 September 2019.

Eligibility:

  • Must have have less than 10 years’ post-PhD experience.
  • Must be available to present at the ARUK Research Conference in Newport, Wales in March 2020

View an example application form

David Edward Hague, 1942–2015

David Edward HagueDavid was born in Stockport, a working class boy with a free spirit; an optimist, funny and curious. He was also blessed with an outstanding brain. The first in his family to go to university, he read biochemistry at Liverpool and hitchhiked to new worlds in the holidays. In 1966 he moved south to St Mary’s Hospital in London to begin his medical research and continue his sporting activities. His doctoral thesis, Some biochemical aspects of thalidomide toxicity, was a significant contribution to understanding how the sedative thalidomide, given to expectant mothers to ease morning sickness, was able to exert its disastrous effects on the unborn child. He subsequently moved to Barts Hospital and trained in medicine. Various clinical and research roles in the UK and US followed, and in 1982, after becoming a full-time single parent, he settled in Finchley as a GP.

David Edward HagueDavid was charming, kind and clever, and mostly lucky. But soon after retirement he developed Alzheimer’s disease. He coped well for several years, knowing that no cure existed but hoping and trusting that one would be found for his grandchildren’s generation. Alzheimer’s ultimately robbed him of his intellect and his independence, and, on 7th September 2015, his life.

The Judging Panel:

This year our Judging Panel consists of world leading scientists in dementia research with broad expertise that spans many aspects of neurodegeneration.      

Prof Tara Spires-Jones (Chair) University of Edinburgh
Prof Caroline Herron University College Dublin
Prof Colin Masters University of Melbourne
Prof Craig Ritchie University of Edinburgh
Prof Delphine Boche University of Southampton
Dr Elena Di Daniel University of Oxford
Dr Frances Wiseman University College London
Dr James Duce University of Cambridge
Dr Jon Brown University of Exeter
Dr Julie Simpson University of Sheffield
Dr Patrick Lewis University of Reading
Dr Riccardo Marioni University of Edinburgh
Dr Selina Wray University College London
Prof Seth Love University of Bristol
Dr Shahid Zaman University of Cambridge
Dr Stephen Wharton University of Sheffield
Dr Wendy Noble King’s College London